Eravacycline clinical trials
Also written TP-434.
How each study uses eravacycline is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the eravacycline studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 27 Aug 2018 · XERAVA · NDA 211109 (FDA, Drugs@FDA)
- European Union
- 20 Sept 2018 · Xerava · EMEA/H/C/004237 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
14 studies that test it; most in 2013 (3)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 10 · Other 4
Tetraphase Pharmaceuticals, Inc. (9) · IRCCS Azienda Ospedaliero-Universitaria di Bologna (1) · Tetraphase Pharmaceuticals, Inc (1) · West Virginia University (1) · Clinical Hospital Centre Zagreb (1) · National University of Singapore (1)
Often tested with
Tested in the same studies.
Avibactam, ceftazidime drug combination (2) · Meropenem and vaborbactam (2) · Cefiderocol (2) · Aztreonam (2) · Tigecycline (2) · Fosfomycin (2) · Sulbactam (2) · Imipenem (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test eravacycline.
- Dec 2026Therapeutic Options for CRABPhase 4 · Clinical Hospital Centre Zagreb
Studies
Open first, then newest update. How each study uses eravacycline is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 14
- Targeted Versus Standard Peri-operative Antibiotic Prophylaxis in Patients Colonized With Carbapenemase Producing Enterobacterales Undergoing Liver TransplantationNot yet recruitingPhase 3IRCCS Azienda Ospedaliero-Universitaria di BolognaNCT07759453Written as Eravacycline
- A Study to Evaluate the Safety and Tolerability of Eravacycline in Pediatric Patients Aged 8 to 17 With Complicated Intra-abdominal Infections (cIAI)RecruitingPhase 2Tetraphase Pharmaceuticals, IncNCT06794541Written as IV Eravacycline 2mg/kg
- Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged NeutropeniaRecruitingPhase 2West Virginia UniversityNCT05537896Written as Eravacycline
- Therapeutic Options for CRABRecruitingPhase 4Clinical Hospital Centre ZagrebNCT06440304Written as Eravacycline
- Optimising TREATment for Severe Gram-Negative Bacterial InfectionsRecruitingPhase 4National University of SingaporeNCT07004049Written as Colistin/Polymyxin B + Tigecycline/Eravacycline
- Efficacy and Safety Study of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract InfectionsCompletedPhase 3Tetraphase Pharmaceuticals, Inc.NCT01978938Written as Eravacycline
- Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal InfectionsCompletedPhase 3Tetraphase Pharmaceuticals, Inc.NCT01844856Written as Eravacycline
- Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal InfectionsCompletedPhase 3Tetraphase Pharmaceuticals, Inc.NCT02784704Written as Eravacycline
- Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Participants With Complicated Urinary Tract InfectionsCompletedPhase 3Tetraphase Pharmaceuticals, Inc.NCT03032510Written as Eravacycline
- Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal InfectionsCompletedPhase 2Tetraphase Pharmaceuticals, Inc.NCT01265784Written as TP-434
- A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With End Stage Renal Disease and Healthy SubjectsCompletedPhase 1Tetraphase Pharmaceuticals, Inc.NCT02135276Written as eravacycline
- Safety and Pharmacokinetic (PK) Study to Assess Bronchopulmonary Disposition of IV Eravacycline (TP-434) in Healthy Men and WomenCompletedPhase 1Tetraphase Pharmaceuticals, Inc.NCT01989949Written as TP-434 (Eravacycline) reconstituted and administered via an IV infusion
- A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With Impaired Hepatic Function and Healthy SubjectsCompletedPhase 1Tetraphase Pharmaceuticals, Inc.NCT02135302Written as eravacycline
- A Safety and PK Study of IV EravacyclineCompletedPhase 1Tetraphase Pharmaceuticals, Inc.NCT03696550Written as Eravacycline (TP-434)
Codes
What other systems call eravacycline · ClinicalTrials.gg INT006022
- MeSH (NLM) C571179eravacyclineOne source NLM
- UNII (FDA) 07896928ZCERAVACYCLINEConfirmed FDA, NLM, Wikidata
- RxNorm 2055906One source FDA
- Wikidata Q15410941eravacyclineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C171907EravacyclineOne source FDA
- DrugBank DB12329One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C571179 | eravacycline | One source NLM |
| UNII (FDA) | 07896928ZC | ERAVACYCLINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2055906 | — | One source FDA |
| Wikidata | Q15410941 | eravacycline | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C171907 | Eravacycline | One source FDA |
| DrugBank | DB12329 | — | One source Wikidata |
Also registered as eravacycline dihydrochloride (UNII WK1NMH89VJ · RxNorm 2055907).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.